Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Small RNA-Argonaute pathways
- Argonaute proteins
- Targeting promoters by dsRNA
- Gene activation by promoter-targeted dsRNAs
- RNAa timeline
- Questions to be addressed
- RNAa requires Ago2
- RNAa has slow kinetics
- Chromatin Isolation by ChIbRP
- RNAa is an on-target effect (1)
- RNAa is an on-target effect (2)
- RNAa is an on-target effect (3)
- Success rate of saRNA design
- RNAa and promoter DNA methylation
- RNAa induces transcription initiation & elongation
- Characterizing the RITA complex
- Proteins associated with saRNA guide strand
- Characterizing the RITA complex
- saRNA-induced CTR9 enrichment at promoter
- CTR9 and RHA are required for RNAa
- saRNA targeting induces H2Bub1
- A working model for RNAa
- Summary
- Acknowledgments
Topics Covered
- The small RNA-Argonaute pathways and negative regulation of gene expression
- Targeting promoters by double-stranded RNA (dsRNA)
- RNAa effects
- Characterizing the RITA complex
- A working model for RNAa
Talk Citation
Li, L. (2017, April 30). Activation of gene expression by double-stranded RNAs [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/ZVFT2076.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Long-Cheng Li has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Cell Biology
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name is Long-Cheng Li.
I'm a professor at the Peking
Union Medical College Hospital,
of the Chinese Academy of Medical Sciences.
The title of my talk today
is "Activation of Gene Expression
by Double-Stranded RNAs".
0:16
So my topic on small-RNAs or sRNAs,
such as siRNAs and the microRNAs
are known to trigger an evolutionary conservative phenomenon, known as RNAi.
In RNAi,
siRNA is either exogenously introduced
or produced within the cells are loaded
by a protein called Argonaute
or Ago in short.
The Ago protein would even discard
one of the RNA strand in the RNA duplex.
And it uses the remaining RNA strand
as the guide to form an active complex
called RNA-induced
silencing complex or RISC.
The complex then bonds to complementary
mRNA sequences leading to mRNA degradation.
If the guide RNA is a microRNA,
they often bind to the 3’UTR region
of mRNA, resulting in mRNA degradation
and/or suppression of the translation.
RNAi is mainly a set proximate event.
The nuclear function of small RNAs
and the protein partners Argonautes
is naturally alone,
except in plants and in some lower eukaryotes,
such as fission yeast and Drosophila.
In plants, the small RNA-Ago pathway
can initiate lower DNA methylation,
a phenomenon known
as RNA-directed DNA methylation or RdDM,
leading to transcriptional gene silencing.
In fission yeast and in Drosophila, RNA pathway
can mediate the assembly and maintenance
of heterochromatin
at the centromere regions,
which is required
to silence repetitive sequences.
However, the nuclear function
of this small RNA-Ago pathways
in mammalian cells remains a mystery,
which will be the topic
of my presentation today.